It is well worth mentioning that enhancements are created in developing sublingual tablet formulations that goal to improve taste and dissolve time. By way of example, OX219 (Zubsolv®) is usually a novel sublingual tablet formulation of buprenorphine/naloxone that received noticeably higher scores for taste and overall acceptability in comparison